27395784|t|Lateral hypothalamus orexinergic system modulates the stress effect on pentylenetetrazol induced seizures through corticotropin releasing hormone receptor type 1
27395784|a|Stress is a trigger factor for seizure initiation which activates hypothalamic pituitary adrenal (HPA) axis as well other brain areas. In this respect, corticotropin releasing hormone (CRH) and lateral hypothalamus (LH) orexinergic system are involved in seizure occurrence. In this study, we investigated the role of LH area and orexin expression in (mediation of) stress effect on pentylenetetrazol (PTZ) - induced seizures with hippocampal involvement. Two mild foot shock stresses were applied to intact and adrenalectomized animals; with or without CRHr1 blocking (NBI 27914) in the LH area. Then, changes in orexin production were evaluated by RT-PCR. Intravenous PTZ infusion (25 mg/ml) - induced convulsions were scored upon modified Racine scale. Finally, hippocampal glutamate and GABA were evaluated to study excitability changes. We demonstrated that the duration and severity of convulsions in stress - induced as well as adrenalectomized group were increased. Plasma corticosterone (CRT) level and orexin mRNA expression were built up in the stress and/or seizure groups. Furthermore, glutamate and GABA content was increased and decreased respectively due to stress and seizures. In contrast, rats receiving CRHr1 inhibitor showed reduced severity and duration of seizures, increased GABA, decreased glutamate and corticosterone and also orexin mRNA compared to the inhibitor free rats. Stress and adrenalectomy induced augmenting effect on seizure severity and duration and the subsequent reduction due to CRHr1 blocking with parallel orexin mRNA changes, indicated the likely involvement of CRH1r induced orexin expression of the LH in gating stress effect on convulsions.
27395784	0	39	Lateral hypothalamus orexinergic system	T022	C0460002
27395784	40	49	modulates	T082	C0443264
27395784	54	60	stress	T046	C0449430
27395784	61	67	effect	T080	C1280500
27395784	71	88	pentylenetetrazol	T109,T121	C0030903
27395784	89	96	induced	T169	C0205263
27395784	97	105	seizures	T184	C0036572
27395784	114	161	corticotropin releasing hormone receptor type 1	T116,T192	C0529997
27395784	162	168	Stress	T046	C0449430
27395784	174	200	trigger factor for seizure	T201	C1303052
27395784	201	211	initiation	T169	C1704686
27395784	218	227	activates	T052	C1879547
27395784	228	269	hypothalamic pituitary adrenal (HPA) axis	T022	C0597719
27395784	260	263	HPA	T022	C0597719
27395784	284	289	brain	T023	C0006104
27395784	290	295	areas	T082	C0205146
27395784	314	345	corticotropin releasing hormone	T116,T121,T125	C0010132
27395784	346	351	(CRH)	T116,T121,T125	C0010132
27395784	356	376	lateral hypothalamus	T029	C0020654
27395784	356	400	lateral hypothalamus (LH) orexinergic system	T022	C0460002
27395784	378	380	LH	T029	C0020654
27395784	405	413	involved	T169	C1314939
27395784	417	424	seizure	T184	C0036572
27395784	425	435	occurrence	T079	C2745955
27395784	445	450	study	T062	C2603343
27395784	455	467	investigated	T169	C1292732
27395784	472	476	role	T169	C0542341
27395784	480	487	LH area	T029	C0020654
27395784	492	498	orexin	T116,T123	C1113688
27395784	499	509	expression	T045	C1171362
27395784	514	523	mediation	UnknownType	C0814912
27395784	528	534	stress	T046	C0449430
27395784	535	541	effect	T080	C1280500
27395784	545	562	pentylenetetrazol	T109,T121	C0030903
27395784	563	568	(PTZ)	T109,T121	C0030903
27395784	571	578	induced	T169	C0205263
27395784	579	587	seizures	T184	C0036572
27395784	593	604	hippocampal	T023	C0019564
27395784	605	616	involvement	T169	C1314939
27395784	622	626	mild	T080	C4316743
27395784	627	646	foot shock stresses	T046	C0449430
27395784	652	659	applied	T169	C4048755
27395784	663	669	intact	T080	C0205266
27395784	674	690	adrenalectomized	T061	C0001632
27395784	691	698	animals	T008	C0003062
27395784	716	721	CRHr1	T116,T192	C0529997
27395784	722	730	blocking	T169	C0332206
27395784	732	741	NBI 27914	T109	C1174222
27395784	750	757	LH area	T029	C0020654
27395784	765	772	changes	T169	C0392747
27395784	776	782	orexin	T116,T123	C1113688
27395784	799	808	evaluated	T058	C0220825
27395784	812	818	RT-PCR	T063	C0599161
27395784	820	831	Intravenous	T082	C0348016
27395784	832	835	PTZ	T109,T121	C0030903
27395784	836	844	infusion	T061	C0574032
27395784	858	865	induced	T169	C0205263
27395784	866	877	convulsions	T184	C4048158
27395784	883	889	scored	T081	C0449820
27395784	895	916	modified Racine scale	T170	C0282574
27395784	927	938	hippocampal	T023	C0019564
27395784	939	948	glutamate	T116,T123	C0220839
27395784	953	957	GABA	T116,T123	C0016904
27395784	963	972	evaluated	T058	C0220825
27395784	976	981	study	T062	C2603343
27395784	982	994	excitability	T184	C0235169
27395784	995	1002	changes	T169	C0392747
27395784	1029	1037	duration	T079	C0449238
27395784	1042	1050	severity	T080	C0439793
27395784	1054	1065	convulsions	T184	C4048158
27395784	1069	1075	stress	T046	C0449430
27395784	1078	1085	induced	T169	C0205263
27395784	1097	1113	adrenalectomized	T061	C0001632
27395784	1125	1134	increased	T081	C0205217
27395784	1136	1142	Plasma	T031	C0032105
27395784	1143	1157	corticosterone	T109,T121,T125	C0010124
27395784	1158	1163	(CRT)	T109,T121,T125	C0010124
27395784	1174	1180	orexin	T028	C1415500
27395784	1181	1196	mRNA expression	T045	C1515670
27395784	1218	1224	stress	T046	C0449430
27395784	1232	1239	seizure	T184	C0036572
27395784	1240	1246	groups	T078	C0441833
27395784	1261	1270	glutamate	T116,T123	C0220839
27395784	1275	1279	GABA	T116,T123	C0016904
27395784	1292	1301	increased	T081	C0205217
27395784	1306	1315	decreased	T081	C0205216
27395784	1336	1342	stress	T046	C0449430
27395784	1347	1355	seizures	T184	C0036572
27395784	1370	1374	rats	T015	C0034721
27395784	1385	1390	CRHr1	T116,T192	C0529997
27395784	1391	1400	inhibitor	T080	C1999216
27395784	1408	1415	reduced	T080	C0392756
27395784	1416	1424	severity	T080	C0439793
27395784	1429	1437	duration	T079	C0449238
27395784	1441	1449	seizures	T184	C0036572
27395784	1451	1460	increased	T081	C0205217
27395784	1461	1465	GABA	T116,T123	C0016904
27395784	1467	1476	decreased	T081	C0205216
27395784	1477	1486	glutamate	T116,T123	C0220839
27395784	1491	1505	corticosterone	T109,T121,T125	C0010124
27395784	1515	1521	orexin	T116,T123	C1113688
27395784	1522	1526	mRNA	T114,T123	C0035696
27395784	1527	1535	compared	T052	C1707455
27395784	1543	1552	inhibitor	T080	C1999216
27395784	1558	1562	rats	T015	C0034721
27395784	1564	1570	Stress	T046	C0449430
27395784	1575	1588	adrenalectomy	T061	C0001632
27395784	1589	1596	induced	T169	C0205263
27395784	1597	1607	augmenting	T169	C0442808
27395784	1608	1614	effect	T080	C1280500
27395784	1618	1625	seizure	T184	C0036572
27395784	1626	1634	severity	T080	C0439793
27395784	1639	1647	duration	T079	C0449238
27395784	1667	1676	reduction	T080	C0392756
27395784	1684	1689	CRHr1	T116,T192	C0529997
27395784	1690	1698	blocking	T169	C0332206
27395784	1713	1719	orexin	T028	C1415500
27395784	1720	1724	mRNA	T114,T123	C0035696
27395784	1725	1732	changes	T169	C0392747
27395784	1734	1743	indicated	T033	C1444656
27395784	1755	1766	involvement	T169	C1314939
27395784	1770	1775	CRH1r	T116,T192	C0529997
27395784	1776	1783	induced	T169	C0205263
27395784	1784	1790	orexin	T116,T123	C1113688
27395784	1791	1801	expression	T061	C0185117
27395784	1809	1811	LH	T029	C0020654
27395784	1822	1828	stress	T046	C0449430
27395784	1829	1835	effect	T080	C1280500
27395784	1839	1850	convulsions	T184	C4048158